PATENT DUCTUS ARTERIOSUS - GOOD AND EVIL IN ONE VESSEL

Cover Page

Abstract


Literature review discusses questions of hemodynamic significance of Patent Ductus Arte-riosus, methods of its surgical and drug (non-surgical) treatment and features in premature newborns.


About the authors

E L Bokerya

RUDN University (Peoples’ Friendship University of Russia), Moscow, Russia

Author for correspondence.
Email: konovalov_oe@rudn.university
117198, г. Москва, ул. Миклухо-Маклая, 6

E A Degtyareva

RUDN University (Peoples’ Friendship University of Russia), Moscow, Russia

Email: dib6@yandex.ru
117198, г. Москва, ул. Миклухо-Маклая, 6

References

  1. Bokeria L. A. & Shatalov K. V. Pediatric Cardiosurgery. A guide for doctors. M.: FGBU «NCSSH im. A.N. Bakuleva» MZ RF. 2016. 864 s.
  2. Heymann M. A., Rudolph A. M. & Silverman N. H. Closure of the ductusarteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med. 1976. Vol. 295. Р. 530—533.
  3. Patel J., Marks K. A., Roberts I., Azzopardi D. & Edwards A. D. Ibuprofen treatment of patent ductus arteriosus. Lancet. 1995. Vol. 346. № 8969. Р. 255.
  4. Volodin N. N. & Baybarina E. N. Protocol for the management of premature infants with a hemo-dynamically significant functioning arterial duct: Methodological recommendations. М.: РАСПМ, 2010. 28 s.
  5. Nemerofsky S. L. et al. The ductus arteriosus rarely requires treatment in infants > 1000 grams. Am J Perinatol. 2008. № 25. Р. 661—666.
  6. Herrman Ket. Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed. 2009. № 94. Р. F48—50.
  7. Fowlie P. W., Davis P. G. & McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2009. Р. 419—471.
  8. Mosalli R., Alfaleh K. & Paes B. Role of prophylactic surgical ligation of patent ductus arteriosus in extremely low birth weight infants: Systematic review and implications for clinical practice. Ann Pediatr Cardiol. 2009. № 2. Р. 120—126.
  9. Clyman R., Cassady G., Kirklin J. K., Collins M. & Philips J. B. The role of patent ductusarte¬riosus ligation in broncho pulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr. 2009. № 154. Р. 873—876.
  10. Sinha B. Controversies in Management of Patent Ductus Arterious in the Preterm Infant. J Pulmon Resp Med. 2009. № 13. Р. 7.
  11. Van Overmeire B., Van de Broek H., Van Laer P., Weyler J. & Vanhaesebrouck P. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory dis-tress syndrome. J Pediatr. № 138. Р. 205—211.
  12. Hammerman C., Bin-Nun A., Markovitch E., Schimmel M. S., Kaplan M., et al. Ductal closure with paracetamol: a surprising new approach to patent ductusarteriosus treatment. Pediatrics. 2011. № 128. Р. 1618—1621.
  13. Van der Lugt N.M., Lopriore E., Bökenkamp R., Smits-Wintjens V.E., Steggerda S. J., et al. Re-peated courses of ibuprofen are effective in closure of a patentductusarteriosus. Eur J Pediatr. 2012. № 171. Р. 1673—1677.
  14. Ohlsson A., Walia R. & Shah S. S. Ibuprofen for the treatment of patent ductus arteriosus in pre-term or low birth weight (or both) infants. Cochrane Database of Systematic Reviews 2015, Issue 2. Art. No.: CD003481. doi: 10.1002/14651858.CD003481.pub6.
  15. Dolk H., Loane M. & Garne E. Congenital heart defects in Europe: prevalence and perinatal mor-tality, 2000 to 2005. Circulation. 2011. Vol. 123. № 8. Р. 841—849.
  16. Tanner K., Sabrine N. & Wren C. Cardiovascular malformations among preterm infants. Pediat-rics. 2005. Vol. 116. № 6. Р. 833—838.
  17. Kemper A. R., Mahle W. T., Martin G. R., Cooley W. C., Kumar P., Morrow W. R., Kelm K., Pearson G. D., Glidewell J., Grosse S. D. & Howell R. R. Strategies for Implementing Screening for Critical Congenital Heart Disease. Pediatrics. 2011. Vol. 128. Р. 1259—1267.
  18. Lhost J. J., Goetz E. M., Belling J. D., vanRoojen W. M., Spicer G. & Hokanson J. S. Pulse¬oximetry screening for critical congenital heart disease in planned out-of-hospitalbirths. J Pediatr. 2014. Vol. 165. № 3. P. 485—489.
  19. Mahle W. T., Newburger J. W., Matherne G. P., Smith F. C., Hoke T. R., Koppel R., Gid¬ding S. S., Beekman III R. H. & Grosse S. D. Role of Pulse Oximetry in Examining Newborns for Con-genital Heart Disease: A Scientific Statement from the AHA and AAP. Pediatrics. 2009. Vol. 124. P. 823—836.
  20. Shkol'nikova M. A., Bokerija E. L., Degtjareva E. A., Il’in V. N. & Sharykin E. S. Neonatal screening to identify critical congenital heart disease. Guidelines № 12. М.: ООО «М-Арт». 2012. 36 с.

Statistics

Views

Abstract - 330

PDF (Russian) - 3064

Cited-By


PlumX

Dimensions


Copyright (c) 2017 Bokerya E.L., Degtyareva E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies